Hemispherx Biopharma, Inc. (HEB) Reports Q2 Loss of $0.02
Tweet
Share
E-mailGet Alerts HEB Hot Sheet
Price: $1.80 --0%
Financial Fact:
Research and development: 900K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 900K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q2 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
- S&P 500 may pull back before midterms, but Citi says buy the dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
